Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate – A nano-strategic approach and comparative assessment of hepatospecificity

Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting – Synthesis and comparative in silico and in vitro assessment

(2021) V. Dhawan et al.   CARBOHYDRATE RESEARCH

Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles

(2020) Yun Bian et al.   Drug Design Development and Therapy

Pharmacokinetic and pharmacodynamic evaluation of resveratrol loaded cationic liposomes for targeting hepatocellular carcinoma

(2020) Satveer Jagwani et al.   ACS Biomaterials-Science & Engineering

Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma

(2019) Harshita et al.   AAPS PHARMSCITECH

PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure

(2018) Lingxuan Mo et al.   Nanomedicine-Nanotechnology Biology and Medicine

Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy

(2017) Jing Zhang et al.   Nanomedicine

Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silic o modeling, in vitro and in vivo evaluation

(2016) Pankaj Pathak et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Stearylated cycloarginine nanosystems for intracellular delivery – simulations, formulation and proof of concept

(2016) V. Dhawan et al.   RSC Advances

Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery

(2015) Pankaj Omprakash Pathak et al.   CARBOHYDRATE RESEARCH

Comparison of Sorafenib-Loaded Poly (Lactic/Glycolic) Acid and DPPC Liposome Nanoparticles in the in Vitro Treatment of Renal Cell Carcinoma

(2015) James Liu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Diagnostic imaging and therapeutic application of nanoparticles targeting the liver

(2015) Haolu Wang et al.   Journal of Materials Chemistry B

Liposomes for targeting hepatocellular carcinoma: Use of conjugated arabinogalactan as targeting ligand

(2014) Sanket M. Shah et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Apoptosis induction and anti-cancer activity of LeciPlex formulations

(2014) Vivek V. Dhawan et al.   CELLULAR ONCOLOGY

Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib

(2012) Taiga Otsuka et al.   HEPATOLOGY RESEARCH

Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles

(2012) Hong Zhang et al.   International Journal of Nanomedicine

In vitroandin vivostudies of galactose-modified liver-targeting liposomes

(2012) Bohong Guo et al.   JOURNAL OF DRUG TARGETING

Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer

(2012) Do Kim et al.   Nanoscale Research Letters

Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat

(2011) Xue-qing Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid

(2010) Werner J. Heinz et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin

(2009) Devyani Dube et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma

(2008) Zhenghong Xu et al.   BIOMATERIALS